Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 15 of 100
Newsletters
Johnson & Johnson CIO says employee upskilling is key to transforming health care
By
John Kell
April 3, 2024
Health
‘This is an emergency’: Trade group warns nearly a third of all independent pharmacies will go extinct because of a CMS rule
By
Maia Anderson
,
Healthcare Brew
and
Morning Brew
March 30, 2024
Retail
Walgreens’ frail quarter goes beyond the discretionary spending dips afflicting its competitors. It’s ‘just not very good at retailing,’ analyst says
By
Sasha Rogelberg
March 29, 2024
Commentary
The economics of antibiotics are broken and superbugs are on the rise–but a solution inspired by the subscription economy could save millions of lives
By
Howard Dean
March 28, 2024
Health
Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
By
Madison Muller
,
Robert Langreth
and
Bloomberg
March 28, 2024
Leadership
China woos CEOs of Apple, chipmakers, pharma giants as geopolitical tensions mount: ‘The risk-reward has changed’
By
Bloomberg
March 23, 2024
Commentary
Bayer CEO: Corporate bureaucracy belongs in the 19th century. Here’s how we’re fighting it
By
Bill Anderson
March 21, 2024
Life
An exercise pill may soon offer the same benefits as a workout, scientists say
By
Lindsey Leake
March 18, 2024
Newsletters
How AI turbocharged the development of a new drug and what it might mean for health care
By
Diane Brady
March 14, 2024
Health
FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer’s drug
By
Tom Murphy
,
Matthew Perrone
and
The Associated Press
March 8, 2024
Health
Mark Cuban’s $141K mistake: The Cost Plus Drugs cofounder says CEOs don’t understand health care coverage, and it’s costing them big
By
Lindsey Leake
March 8, 2024
Health
Bayer CEO compares the state of troubled pharma group to the time he fractured his leg skateboarding: ‘We’re badly broken in 4 places’
By
Ryan Hogg
March 6, 2024
Retail
Novo Nordisk’s Wegovy and Ozempic boom saved Denmark’s GDP from a no-growth 2023—and will help double its expected growth this year, country’s largest bank says
By
Niclas Rolander
and
Bloomberg
March 5, 2024
Health
Mark Cuban’s Cost Plus Drugs will begin manufacturing its own medications this week
By
Lindsey Leake
March 5, 2024
Health
First over-the-counter birth control pill in U.S. begins shipping to stores
By
Matthew Perrone
and
The Associated Press
March 4, 2024
Most Popular
Economy
'I just don't have a good feeling about this': Top economist Claudia Sahm says the economy quietly shifted and...
By
Eleanor Pringle
Success
Ryan Serhant starts work at 4:30 a.m.—he says most people don’t achieve their dreams because ‘what they really want is...
By
Preston Fore
Future of Work
Ford CEO has 5,000 open mechanic jobs with up to 6-figure salaries from the shortage of manually skilled workers: 'We...
By
Marco Quiroz-Gutierrez